Anne Coleman to Ocular Hypertension
This is a "connection" page, showing publications Anne Coleman has written about Ocular Hypertension.
Connection Strength
1.323
-
Applying an evidence-based approach to the management of patients with ocular hypertension: evaluating and synthesizing published evidence. Am J Ophthalmol. 2004 Sep; 138(3 Suppl):S3-10.
Score: 0.228
-
Initial clinical experience with the Ahmed glaucoma valve implant--correction. Am J Ophthalmol. 1995 Nov; 120(5):684.
Score: 0.124
-
Initial clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1995 Jul; 120(1):23-31.
Score: 0.121
-
Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover study. Ophthalmology. 1992 Mar; 99(3):424-9.
Score: 0.096
-
Displacement of the optic nerve head by acute changes in intraocular pressure in monkey eyes. Ophthalmology. 1991 Jan; 98(1):35-40.
Score: 0.089
-
The logic behind target intraocular pressure. Am J Ophthalmol. 2009 Mar; 147(3):379-80.
Score: 0.078
-
Risk factors for glaucoma onset and progression. Surv Ophthalmol. 2008 Nov; 53 Suppl1:S3-10.
Score: 0.076
-
Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study. Am J Ophthalmol. 2004 Oct; 138(4):684-5.
Score: 0.057
-
Risk assessment in the management of patients with ocular hypertension. Am J Ophthalmol. 2004 Sep; 138(3):458-67.
Score: 0.057
-
The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors. Am J Ophthalmol. 2004 Feb; 137(2):219-27.
Score: 0.055
-
Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Arch Ophthalmol. 2004 Jan; 122(1):22-8.
Score: 0.054
-
A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension. Ophthalmology. 2003 Dec; 110(12):2362-8.
Score: 0.054
-
Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology. 1998 Nov; 105(11):2112-6.
Score: 0.038
-
Aqueous shunts for glaucoma. Cochrane Database Syst Rev. 2017 07 28; 7:CD004918.
Score: 0.035
-
The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty. Ophthalmology. 1993 Jul; 100(7):1083-8.
Score: 0.026
-
The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Am J Ophthalmol. 2013 Jun; 155(6):971-82.
Score: 0.026
-
Structure-function relationships between spectral-domain OCT and standard achromatic perimetry. Invest Ophthalmol Vis Sci. 2012 May 09; 53(6):2740-8.
Score: 0.024
-
Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study. Ophthalmology. 2010 Sep; 117(9):1674-83.
Score: 0.021
-
Incorporating mortality risk into estimates of 5-year glaucoma risk. Am J Ophthalmol. 2009 Dec; 148(6):925-31.e7.
Score: 0.020
-
A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol. 2006 Jan; 124(1):12-9.
Score: 0.016
-
Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2005 Sep; 123(9):1188-97.
Score: 0.015
-
Depression in patients with glaucoma as measured by self-report surveys. Ophthalmology. 2002 May; 109(5):1018-22.
Score: 0.012